Ipilimumab in Pretreated Patients With Advanced Malignant Melanoma: Results of the South African Expanded-Access Program

Ipilimumab in Pretreated Patients With Advanced Malignant Melanoma: Results of the South African Expanded-Access Program

Purpose: The primary objective of this study was to evaluate 1- and 2-year survival rates and durable remissions in pretreated patients with advanced (unresectable or metastatic) malignant melanoma treated with ipilimumab in a South African expanded-access program (SA-EAP). Patients and Methods: Thi...

Full description

Bibliographic Details
Main Authors: Bernardo L. Rapoport, Daniel A. Vorobiof, Lydia M. Dreosti, Adam Nosworthy, Georgina McAdam, Johan P. Jordaan, Helen Miller-Jansön, Margreet de Necker, Janetta C. de Beer, Hennie Duvenhage
Format: Article
Language:English
Published: American Society of Clinical Oncology 2017-10-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.2016.006544

Internet

http://ascopubs.org/doi/10.1200/JGO.2016.006544

Similar Items